Survey, Family LifeNCT05182216
Social Media Use in Sickle Cell Patients
An observational study of Survey, Family Life, run by University of Alabama at Birmingham.
Trial summary
Surveys of patients to identify primary social media sources for health news. Read more about this study
- Who is it for?
- Ages 18 years and olderHealthy volunteers can take part
- Conditions the study is for
- Survey, Family Life
- How many people
- 0 participants
- Where
- No sites listed yet
- Study dates
- 1 Jan 2023to 31 Dec 2023
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- Healthy volunteers accepted
- Adult, Older adult
Study population: Adults with diagnosis of sickle cell disease
Who may be able to join
- sickle cell disease diagnosis
Who cannot join
- negative sickle cell disease diagnosis
About this study
Surveys of patients to identify primary social media sources for health news.
- Conditions
- Survey, Family Life
What is being measured
The primary outcome is the main question the study is designed to answer.
Social Media Use in Sickle Cell Patients
Surveys. The survey will have a variety of social media options and ask participants to select the medium used to receive information on health, news, and entertainment.
Measured: six months
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted10 Jan 2022
- Study start1 Jan 2023 (estimated)
- Primary completion31 Dec 2023 (estimated)
- Study completion31 Dec 2023 (estimated)
Why it stopped: We have withdrawn this study.
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Survey, Family LifeStudies of the same condition, open and under way.
- More trials run by University of Alabama at BirminghamThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Ecologic or community
- Time perspective
- Cross-sectional
- Enrolment
- 0 participants (actual)
Sponsor and investigators
- Lead sponsor
- University of Alabama at Birmingham
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Sonja Smith, University of Alabama at Birmingham
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT05182216
- Sponsor's protocol ID
- 300007766
- Status last verified
- Jan 2023
- First submitted
- 22 Nov 2021
- Last updated
- 6 Jan 2023
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
Study at a glance
From the registry record, last updated by the sponsor on 6 Jan 2023. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Social Media Use in Sickle Cell Patients
- ClinicalTrials.gov ID
- NCT05182216
- Acronym / sponsor ID
- 300007766
- Conditions
- Survey, Family Life
- Study type
- Observational
- Recruitment status
- WithdrawnReason stopped: We have withdrawn this study.
- Enrolment
- 0 participants (actual)
- Lead sponsor
- University of Alabama at BirminghamUniversity, hospital or other
- Study start
- 1 Jan 2023 (estimated)
- Primary completion
- 31 Dec 2023 (estimated)
- Study completion
- 31 Dec 2023 (estimated)
- First posted
- 10 Jan 2022 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Surveys of patients to identify primary social media sources for health news.
Study design
- Observational model
- Ecologic or community
- Time perspective
- Cross-sectional
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult, Older adult
- Study population
- Adults with diagnosis of sickle cell disease
Key inclusion criteria (1 listed)
- sickle cell disease diagnosis
Key exclusion criteria (1 listed)
- negative sickle cell disease diagnosis
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Primary outcome
Social Media Use in Sickle Cell Patients
Time frame: six months
Surveys. The survey will have a variety of social media options and ask participants to select the medium used to receive information on health, news, and entertainment.
Results and safety
The study was withdrawn before enrolling participants, so there are no results.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 6 Jan 2023.
Related trials for Survey, Family Life
RecruitingObservational study
Long-Term Burden of BPD and Health-Related Quality of Life (BronQ Family)
Bronchopulmonary Dysplasia (BPD), Chronic Lung Disease of Newborn
RecruitingObservational study
Taiwan Real-world LDCT Screening Behavior and Outcome Research for High Risk Subjects Based on Health Promotion Administration
Lung Cancer, High-Risk Cancer
Active, not recruitingObservational study
Prevalence of Self-disclosed Knee Trouble and Use of Treatments Among Elderly Individuals
Knee Osteoarthritis, Survey, Family Life
Not yet recruitingObservational study
Global Survey on Newborns' HOspitalisation and Parental Experiences - the HOPE Study
Infant, Premature, Infant, Low Birth Weight
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
Questions about this trial
What is this clinical trial studying?
An observational study of Survey, Family Life, run by University of Alabama at Birmingham.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: withdrawn, as of the sponsor's last update on 6 Jan 2023. Status can change between updates, so confirm with the study contact before making plans.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study was withdrawn before enrolling participants, so there are no results.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Social Media Use in Sickle Cell Patients (time frame: six months). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 6 Jan 2023.